Company provides $1.5 million in urgently needed medical supplies; Donates $250,000 in cash grants
Press release reprinted from www.hospira.com - January 22, 2010
LAKE FOREST, Ill., Jan. 22, 2010 -- Hospira, Inc. (NYSE: HSP), a leading global specialty pharmaceutical and medication delivery company, and its philanthropic arm, the Hospira Foundation, have made initial donations of approximately $1.75 million in medical products and cash grants to support humanitarian relief efforts in Haiti. More than 750,000 units of Hospira products, valued at more than $1.5 million, are either in Haiti or en route to the country and include antibiotics, intravenous (I.V.) solutions, analgesics and anesthetics, all of which are in high demand and are integral to serving the needs of disaster victims.
"We are working closely with humanitarian aid agencies to help the people of Haiti obtain access to critical products needed in the provision of medical care," said Christopher B. Begley, chairman and chief executive officer. "The Hospira family expresses deep sympathy to all of the victims of this tragedy, and we will continue to work in the coming weeks and months to provide health and wellness to this devastated region."
In addition to donating products, Hospira has made a total of $200,000 in initial cash grants to the Red Cross and to the company's partners, which include AmeriCares, Direct Relief International, Catholic Medical Mission Board (CMMB) and Project Hope. Hospira also will match employee contributions dollar for dollar up to $50,000 through the Hospira Foundation.
Hospira will continue to monitor disaster relief efforts in Haiti, and will evaluate opportunities to provide additional assistance as further needs and information become available.
For more about Hospira visit www.hospira.com
* * *
Is your company donating medical devices, supplies or other assistance to help the earthquake victims Haiti?
If so, Medical Devices Today would like to hear about it. Please send publication-ready press releases about what your company is doing to Sean Smith at [email protected].
* * *
Make sure you sign up for your FREE weekly email updates including the latest news and analysis from "The Gray Sheet," IN VIVO, Medtech Insight and Start Up.
Comments